Dovetail Medical Events

GLP‑1 Receptor Agonists: How Are These Agents Transforming Obesity and Diabetes? 2nd December 2026 – Free

GLP‑1 Receptor Agonists: How Are These Agents Transforming Obesity and Diabetes? 2nd December 2026 – Free

Live Webinar

2 December 2026 | 12:15 – 13:15 | Free

Book Here

GLP‑1 receptor agonists are reshaping obesity and diabetes care. As treatment pathways evolve, clinicians need clear, practical guidance. This course explains how these therapies work and how to use them confidently in daily practice.

First, you will explore incretin physiology. Then, you will compare GLP‑1 and dual GIP/GLP‑1 receptor agonists. After that, you will review NICE recommendations to ensure your approach aligns with national standards. Moreover, you will learn how to optimise counselling and manage adverse effects effectively.

Because GLP‑1 therapies influence weight, glucose control and cardiovascular outcomes, understanding their mechanisms is essential. Therefore, this session focuses on evidence‑based strategies that improve patient outcomes and support safe prescribing.

In addition, you will gain practical insights to enhance adherence and patient confidence. Consequently, your consultations will become more effective and patient‑centred.

This course is ideal for nurses, GPs, ACPs, pharmacists and allied health professionals. It provides concise, actionable learning that fits seamlessly into clinical practice.